Total Population (n = 17) | Patients with spontaneous clearance (n = 4) | Patients with chronic infections (n = 13) | |
---|---|---|---|
Age, median years (range) | 31 (22–39) | 30 (22–31) | 32 (24–39) |
Sex, n (%) | |||
Men | 15 | 3 (20.0) | 12 (80.0) |
Women | 2 | 1 (50.0) | 1 (50.0) |
Probable mode of HCV transmission, n (%) | |||
Injection drug use | 12 | 2 (16.7) | 10 (83.3) |
Sexual contact | 1 | 1 (100.0) | 0 (0.0) |
Undetermined | 4 | 1 (25.0) | 3 (75.0) |
HCV genotype, n (%) | |||
Genotype 1a | 1 | 1 (100.0) | |
Genotype 1b | 9 | 2 (22.2) | 7 (77.8) |
Genotype 2a/2c | 3 | 1 (33.3) | 2 (66.7) |
Genotype 3a | 4 | 1 (25.0) | 3 (75.0) |